MariMed Inc. (OTCMKTS:MRMD) Short Interest Down 42.2% in April

MariMed Inc. (OTCMKTS:MRMD) saw a significant drop in short interest in the month of April. As of April 30th, there was short interest totaling 20,807 shares, a drop of 42.2% from the April 15th total of 36,003 shares. Based on an average daily volume of 2,603,967 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are sold short.

MariMed Stock Performance

MRMD stock traded up $0.00 during mid-day trading on Monday, reaching $0.07. 420,405 shares of the stock traded hands, compared to its average volume of 575,460. The company has a quick ratio of 0.34, a current ratio of 0.95 and a debt-to-equity ratio of 1.67. MariMed has a 52 week low of $0.06 and a 52 week high of $0.23. The business has a 50-day moving average of $0.08 and a two-hundred day moving average of $0.09. The firm has a market capitalization of $28.54 million, a PE ratio of -2.38 and a beta of 1.33.

MariMed (OTCMKTS:MRMD) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01). MariMed had a negative net margin of 7.82% and a negative return on equity of 5.00%. The company had revenue of $39.48 million during the quarter, compared to analysts’ expectations of $38.75 million. As a group, equities analysts predict that MariMed will post -0.05 EPS for the current fiscal year.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.